Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581M Sell
5,429,711
-46,518
-0.8% -$5.12M 15.71% 3
2026
Q1
$576M Hold
5,476,229
18.46% 3
2025
Q4
$683M Hold
5,476,229
18.68% 3
2025
Q3
$657M Hold
5,476,229
19.27% 3
2025
Q2
$503M Hold
5,476,229
17.73% 3
2025
Q1
$482M Sell
5,476,229
-1,650,000
-23% -$162M 20.24% 3
2024
Q4
$659M Sell
7,126,229
-6,230,384
-47% -$600M 25.58% 2
2024
Q3
$1.24B Hold
13,356,613
38.95% 2
2024
Q2
$1B Sell
13,356,613
-2,468,504
-16% -$197M 33.73% 2
2024
Q1
$1.37B Sell
15,825,117
-12,400,272
-44% -$948M 39.35% 1
2023
Q4
$1.95B Sell
28,225,389
-4,100,000
-13% -$247M 48.81% 1
2023
Q3
$1.77B Buy
+32,325,389
New +$1.84B 74.43% 1

Other funds holding CRH

Cevian Capital II's CRH Position: Q2 2026 in Review

Cevian Capital II reduced its CRH (CRH) stake by 0.85% in Q2 2026, selling an estimated $5.12M and leaving 5,429,711 shares worth $581M. The position accounts for 15.71% of the portfolio, ranked #3.

Cevian Capital II first reported a position in CRH in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.95B in Q4 2023. 1,030 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Cevian Capital II held 5,429,711 shares of CRH worth $581M as of Q2 2026.
  • Cevian Capital II sold 46,518 CRH shares in Q2 2026, an estimated $5.12M.
  • CRH made up 15.71% of Cevian Capital II's portfolio in Q2 2026, its #3 holding.
  • Cevian Capital II first reported a position in CRH in Q3 2023 and has held it in 12 quarters since.
  • Cevian Capital II's CRH position peaked at $1.95B in Q4 2023.
  • 1,030 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Cevian Capital II's 13F filing for Q2 2026, filed 14 Aug 2026.